{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:38:55Z","timestamp":1791283135739,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lipodystrophy in HIV\u2010infected (LDHIV) patients receiving protease inhibitors (PIs) is associated with dyslipidaemia. Whether lifestyle factors play a role in dyslipidaemia in LDHIV subjects on PIs is not well characterized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 45 LDHIV male and six LDHIV female patients on PIs were recruited, and data were collected on smoking, exercise, diet (by 3\u2010day food record), and fasting levels of serum lipids and lipoproteins. The relationships between lifestyle factors and metabolic variables were analysed in male patients by Spearman's correlation test and the significant relationships were further analysed by adjusting for age, PI duration, and waist circumference by Spearman's partial correlation test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In men, mean (\u00b1standard deviation) serum concentrations of total cholesterol (TC), high\u2010density lipoprotein cholesterol (HDL\u2010C), triglycerides (TG), and non\u2010HDL\u2010C were 212\u00b170, 35\u00b17.3, 325\u00b1230 and 169\u00b144\u2003mg\/dL, respectively. Sixty\u2010seven percent of the men exercised regularly and 31.1% smoked. The reported diet was high in cholesterol (390\u00b1212\u2003mg) and percentage energy from saturated (12.2\u00b13.3%) and <jats:italic>trans<\/jats:italic> (2.4\u00b11.2%) fats, and low in soluble fibre (6.9\u00b12.3\u2003g) compared with recent dietary guidelines. Following adjustments for the confounding variables, percentage energy intake from total protein and animal protein was positively related to TC (<jats:italic>r<\/jats:italic>=0.44, <jats:italic>P<\/jats:italic>&lt;0.01 and <jats:italic>r<\/jats:italic>=0.37, <jats:italic>P<\/jats:italic>&lt;0.05, respectively), TG (<jats:italic>r=<\/jats:italic>0.40, <jats:italic>P<\/jats:italic>&lt;0.01 and <jats:italic>r<\/jats:italic>=0.46, <jats:italic>P<\/jats:italic>&lt;0.01, respectively) and non\u2010HDL\u2010C (<jats:italic>r=<\/jats:italic>0.56, <jats:italic>P<\/jats:italic>&lt;0.001 and <jats:italic>r<\/jats:italic>=0.49, <jats:italic>P<\/jats:italic>&lt;0.01, respectively), that from <jats:italic>trans<\/jats:italic> fat was positively related to TG (<jats:italic>r=<\/jats:italic>0.34, <jats:italic>P<\/jats:italic>&lt;0.05), and soluble fibre was negatively related to non\u2010HDL\u2010C (<jats:italic>r<\/jats:italic>=\u22120.41, <jats:italic>P<\/jats:italic>&lt;0.01). Moderate to heavy aerobic exercise tended to be associated with higher HDL\u2010C (<jats:italic>r=<\/jats:italic>0.30, <jats:italic>P<\/jats:italic>=0.07) whereas smoking was not associated with any of the metabolic variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Increased intake of total protein, animal protein and <jats:italic>trans<\/jats:italic> fat, and reduced soluble fibre consumption contribute to dyslipidaemia in LDHIV subjects on PIs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2005.00309.x","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T17:21:05Z","timestamp":1120238465000},"page":"291-298","source":"Crossref","is-referenced-by-count":39,"title":["The role of diet, exercise and smoking in dyslipidaemia in HIV\u2010infected patients with lipodystrophy"],"prefix":"10.1111","volume":"6","author":[{"given":"M","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Adams\u2010Huet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Boonyavarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Quittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WL","family":"Dinges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020794"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00023"},{"key":"e_1_2_6_6_2","first-page":"2093","article-title":"Diagnosis, prediction, and natural course of HIV\u20101 protease\u2010inhibitor\u2010associated lipodystrophy, hyperlipidaemia, and diabetes mellitus","volume":"353","author":"Carr A","year":"1999","journal-title":"a cohort study"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79053-X"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00002030-200102160-00005","article-title":"Premature atherosclerosis in HIV\u2010infected individuals \u2013 focus on protease inhibitor therapy","volume":"15","author":"Depairon M","year":"2001","journal-title":"AIDS"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311210-00010"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030218"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200008180-00020"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/322680"},{"key":"e_1_2_6_14_2","first-page":"1593","article-title":"Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus\u2010positive subjects","volume":"36","author":"Gavrila A","year":"2003","journal-title":"a cross-sectional study"},{"key":"e_1_2_6_15_2","first-page":"1645S","article-title":"n\u20103 fatty acids and serum lipoproteins","volume":"65","author":"Harris W.","year":"1997","journal-title":"human studies"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34389-3"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008163230703"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/54.6.1036"},{"key":"e_1_2_6_19_2","volume-title":"Manual of Laboratory Operations: Lipid Research Clinics Program: Lipid and Lipoprotein Analysis","author":"Department of Health and Human Services, Public Health Service.","year":"1982"},{"key":"e_1_2_6_20_2","first-page":"625","article-title":"Elevated Framingham risk score in HIV\u2010positive patients on highly active antiretroviral therapy","volume":"23","author":"Bergersen BM","year":"2004","journal-title":"results for a Norwegian study of 721 subjects"},{"key":"e_1_2_6_21_2","first-page":"2245S","article-title":"Dietary assessment resource manual","volume":"124","author":"Thompson FE","year":"1994","journal-title":"J Nutr"},{"key":"e_1_2_6_22_2","volume-title":"Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids","author":"Institute of Medicine of the National Academies.","year":"2002"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000038493.65177.94"},{"key":"e_1_2_6_24_2","first-page":"30","article-title":"Cholesterol\u2010lowering effects of dietary fiber","volume":"69","author":"Brown L","year":"1999","journal-title":"a meta-analysis"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005113421903"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)40770-9"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001574-199903000-00002"},{"key":"e_1_2_6_28_2","first-page":"920","article-title":"Fiber and starchy foods","volume":"81","author":"Jenkins D","year":"1986","journal-title":"gut function and implications in disease"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/120.7.800"},{"key":"e_1_2_6_30_2","first-page":"1153S","article-title":"Diet and chronic degerative diseases","volume":"59","author":"Campbell TC","year":"1994","journal-title":"perspectives from China"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ajcn\/59.1.103","article-title":"Blood pressure and blood lipids among vegetarian, semivegetarian, and nonvegetarian African Americans","volume":"59","author":"Melby CL","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114599001373"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906243402501"},{"key":"e_1_2_6_34_2","first-page":"399","article-title":"Hydrogenation alternatives","volume":"33","author":"Zock PL","year":"1992","journal-title":"effects of trans fatty acids and stearic acid versus linolenic acid on serum lipid and lipoproteins in humans"},{"key":"e_1_2_6_35_2","first-page":"861","article-title":"Dietary trans fatty acids","volume":"59","author":"Judd JT","year":"1994","journal-title":"effects on plasma lipids and lipoproteins of healthy men and women"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-2863(03)00106-2"},{"key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0022-2275(20)31510-8","article-title":"Hydrogenated fat consumption affects acylation\u2010stimulating protein level and cholesterol esterification rates in moderately hypercholesterolemic women","volume":"42","author":"Matthan NR","year":"2001","journal-title":"J Lipid Res"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0022-2275(20)32359-2","article-title":"Long\u2010term effects of cis and trans monounsaturated (18:1) and saturated (16:0) fatty acids on the synthesis and secretion of apolipoprotein A\u2010I\u2010 and apolipoprotein B\u2010containing lipoproteins in HepG2 cells","volume":"41","author":"Dashti N","year":"2000","journal-title":"J Lipid Res"},{"key":"e_1_2_6_39_2","first-page":"IV1","article-title":"Epidemiology of plasma high\u2010density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Introduction","volume":"62","author":"Tyroler HA.","year":"1980","journal-title":"Circulation"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200110190-00021"},{"key":"e_1_2_6_41_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1152\/jappl.2001.90.1.133","article-title":"Resistance exercise training reduces hypertriglyceridemia in HIV\u2010infected men treated with antiviral therapy","volume":"90","author":"Yarasheski KE","year":"2001","journal-title":"J Appl Physiol"},{"key":"e_1_2_6_42_2","first-page":"L40","article-title":"Effectiveness of supervised exercise program on fat accumulation and metabolic levels in HIV\u2010infected African\u2010Americans and Latinos","volume":"7","author":"Raghavan S","year":"2002","journal-title":"Antiviral Ther"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200210180-00014"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200403010-00005"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2005.00309.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2005.00309.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:22:59Z","timestamp":1696951379000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2005.00309.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1468-1293.2005.00309.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2005.00309.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}